Table 1: Composition and encapsulation efficiency (%EE) of different niosomal formulations.
Formulation code | Surfactant used | (Surfactant :Cholesterol) weight ratio | Amount of drug (mg) | Encapsulation Efficiency (%EE) |
N-1 | Span 20 | 0.5:0.5 | 5 | 53.2 ± 0.40 |
N-2 | 0.5:0.5 | 10 | 86.2 ± 0.20 |
N-3 | 0.5:0.5 | 15 | 86.2 ± 0.42 |
N-4 | 0.5:1 | 10 | 86.3 ± 0.06 |
N-5 | 0.5:1.5 | 10 | 78.8 ± 0.35 |
N-6 | Span 60 | 0.5:0.5 | 5 | 54.2 ± 0.41 |
N-7 | 0.5:0.5 | 10 | 92.8 ± 0.35 |
N-8 | 0.5:0.5 | 15 | 95.6 ± 0.50 |
N-9 | 0.5:1 | 10 | 93.6 ± 0.06 |
N-10 | 0.5:1.5 | 10 | 90.4 ± 0.45 |
N-11 | Span 80 | 0.5:0.5 | 5 | 44.8 ± 0.45 |
N-12 | 0.5:0.5 | 10 | 64.01 ± 0.39 |
N-13 | 0.5:0.5 | 15 | 71 ± 0.66 |
N-14 | 0.5:1 | 10 | 70 ± 0.28 |
N-15 | 0.5:1.5 | 10 | 75.9 ± 0.4 |